The earnings call presented a strong financial performance with notable revenue growth and strategic product launches, despite challenges from tariffs and a decrease in non-GAAP earnings per share. The company's ability to reaffirm and modestly increase guidance for the full year suggests confidence in overcoming headwinds.

Company Guidance -

Q3 2025

During the Omnicell Second Quarter 2025 Financial Results Call, the company provided updated guidance reflecting a strong first half performance and increased visibility into the remainder of the year. Omnicell reaffirmed its full-year 2025 outlook for product bookings and annual recurring revenue, while modestly increasing its guidance for total revenues, non-GAAP EBITDA, and non-GAAP earnings per share. The company reported total revenue of $291 million for Q2 2025, marking a 5% increase from the same quarter in 2024 and an 8% increase from the previous quarter. GAAP earnings per share were $0.12, up from $0.08 in Q2 2024. Omnicell also highlighted its gross margin improvement, achieving a non-GAAP gross margin of 44.7% for the quarter. The company is navigating tariff impacts, projecting a net tariff impact of approximately $15 million for 2025. Omnicell provided third-quarter revenue guidance between $290 million and $300 million and updated full-year 2025 total revenue guidance to a range of $1.13 billion to $1.16 billion.

Revenue Growth

Total revenue for Q2 2025 was $291 million, representing an increase of $14 million or 5% over Q2 2024 and an increase of $21 million or 8% compared to the previous quarter.

Strong Earnings Performance

Q2 2025 GAAP earnings per share were $0.12 compared to $0.08 in Q2 2024 and a loss of $0.15 in the prior quarter.

Innovation and Product Launches

The company launched several new products, including MedVision and MedTrack - OR, and received HITRUST certification for OmniSphere.

Customer Wins

Significant customer wins across various regions, including a large Northeast health organization and a leading Southern California health system.

Recurring Revenue Growth

The company is scaling its predictable recurring revenue base through service contracts, software subscriptions, and cloud-based offerings.

Omnicell (OMCL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OMCL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	0.37 / -	0.56	―	―	―
Jul 31, 2025	2025 (Q2)	0.27 / 0.45	0.51	-11.76% (-0.06)
May 06, 2025	2025 (Q1)	0.20 / 0.26	0.03	766.67% (+0.23)
Feb 06, 2025	2024 (Q4)	0.58 / 0.60	0.33	81.82% (+0.27)
Oct 30, 2024	2024 (Q3)	0.42 / 0.56	0.62	-9.68% (-0.06)
Aug 01, 2024	2024 (Q2)	0.14 / 0.51	0.57	-10.53% (-0.06)
May 02, 2024	2024 (Q1)	-0.09 / 0.03	0.39	-92.31% (-0.36)
Feb 08, 2024	2023 (Q4)	0.15 / 0.33	0.33	0.00% (0.00)
Nov 02, 2023	2023 (Q3)	0.47 / 0.62	1	-38.00% (-0.38)
Aug 01, 2023	2023 (Q2)	0.28 / 0.57	0.84	-32.14% (-0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OMCL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$29.70	$31.01	+4.41%
May 06, 2025	$30.49	$25.66	-15.84%
Feb 06, 2025	$44.38	$39.43	-11.15%
Oct 30, 2024	$40.12	$53.05	+32.23%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Omnicell (OMCL) report earnings?

Omnicell (OMCL) is schdueled to report earning on Nov 04, 2025, After Close (Confirmed).

What is Omnicell (OMCL) earnings time?

Omnicell (OMCL) earnings time is at Nov 04, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OMCL EPS forecast?

OMCL EPS forecast for the fiscal quarter 2025 (Q3) is 0.37.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing